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Introduction
Low vision and blindness are important public health 
problems. Persons with visual impairment usually need 
support and assistance unless they get vision rehabilita-
tion with the provision of low vision devices, orientation 
and mobility training and counselling for making specif-
ic modifications in their living environment for proper 
adaptation towards performing day to day activities and 
social integration. This process requires extra costs for 
both families and the community. Data from the Insti-
tute for Health Metrics and Evaluation data about Turkey 
showed that sense organ diseases were the second lead-
ing cause of years lost due to disability in 2015 (1). How-
ever, there have been no reliable data showing either the 
baseline causative disorders of visual impairment or the 
burden of these disorders on the population in Izmir re-
gion. 
Izmir is the third most populated city of Turkey with 
a population of approximately 4.2 million. It is located 
in the south-west of the country. Life expectancy is 74.6 
years for males and 80.5 for females. Around 27% of the 
population is over the age of 50 (2,3). 
The purpose of this study was to define the baseline 
disorders causing low vision and blindness in adult 
population of Izmir in accordance with World Health 
Organization (WHO) criteria (4). 
Methods
The medical records of 20 790 people aged ≥ 18 years who 
were admitted to Atatürk Education and Research Hospi-
tal health council to get a health certificate between Jan-
uary 2012 and December 2013 were reviewed retrospec-
tively after the study protocol was approved by the ethics 
committee.
Common reasons for attending the health council 
were to get a health report to be a candidate for certain 
academies and professions, to move nursing homes, to 
get a driving licence, to receive disability benefits (e.g. 
tax discount, nursing services at home, financial support 
assistance) and to be included in the employment quota 
for disabled people.
All attendees had basic ocular examinations, including 
visual acuity testing, slit lamp examination with a dilated 
posterior segment examination and intraocular pressure 
measurement. If the visual acuity level was less than 
20/20, it was retested with the autorefraction result in a 
trial frame to obtain the best-corrected visual acuity. If 
a psychogenic visual acuity loss was suspected, it was 
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retested using several tests for evaluation of psychogenic 
visual loss. If the level of obtained visual acuity was not 
correlated with the ocular findings of the subject, a pattern 
visual evoked potential test was ordered. Subjects were 
referred for visual field screening using the Humphrey 
Perimeter Central 30-2 Swedish Interactive Threshold 
Algorithm when there was pathology affecting the visual 
field. Ocular ultrasonography was ordered when the 
optical medium was not clear enough to visualize the 
retina, and optical coherence tomography was ordered if 
macular or optic disc pathology was suspected. 
Definitions of low vision and blindness
The WHO categories of visual impairment were used for 
this study (4). Visual acuity levels were converted into the 
logarithmic scale equivalents using available conversion 
charts to classify patients according to the WHO criteria. 
Low vision was defined as best-corrected visual acuity 
in the better eye < 20/70 but ≥ 20/400, and blindness was 
defined as best-corrected visual acuity in the better eye 
< 20/400 or visual field constricted within 10° of fixation 
bilaterally (4). 
Causes of low vision or blindness
The principal cause of visual impairment in the eye in 
question was determined by a senior ophthalmologist 
based on clinical records obtained from all examinations 
and available past history and records of the patient. In 
eyes with 2 or more disorders that might have caused 
the visual impairment, the disorder with the presumed 
greatest clinical impact on the visual acuity was consid-
ered the principal cause. If the principal cause of visual 
impairment was different in each eye, the pathology of 
the better eye was considered the principle pathology for 
that patient because low vision and blindness were de-
fined in terms of the better-seeing eye.
Statistical analysis
Descriptive analyses of the data were made using SPSS, 
version 15. All data were reported as mean and standard 
deviation. Continuous variables in the groups were com-
pared using the independent-samples t-test and the cat-
egorical variables were compared using the chi-squared 
test. The level of significance was determined as P < 0.05. 
Results
The total number of patients included in the study was 
347 (172 men, 175 women), who were classified in the low 
vision and blindness category according to WHO criteria 
(4). Seven patients who could not give reliable responses 
to the visual acuity testing because of mental problems 
were excluded.
For better presentation of the pathologies causing 
visual impairment, we categorized all the diseases under 
13 main categories (Table 1). 
The distribution of the pathologies causing low 
vision and blindness according to age and sex is shown 
in Table 2. Distribution of the common pathologies was 
statistically different between age subgroups 18–50 and 
50+ years (P < 0.001), but not between sex subgroups 
(P > 0.05) The most common pathologies causing 
visual impairment were retinal dystrophies, myopic 
degeneration and congenital eye anomalies for the 18–
50 years age group and these were age-related macular 
degenerations, diabetic retinopathy and corneal opacities 
for the 50+ years age group.
Distribution of the pathologies leading to low vision 
and blindness categories according to age is given in 
Table 3. Ten people were classified as either having low 
vision or blind using the visual field criterion and the rest 
using visual acuity. Retinal dystrophies (7 patients) and 
glaucoma (3 patients) were the causes of severe visual 
field constrictions. The severity of visual impairment 
tended to increase with age: blindness was the 
predominant category in the 50+ years age group while 
low vision was predominant in the 18–50 years age group 
(P = 0.063). Pathologies for low vision and blindness in 
Table 1 Disease categorization for visual impairment
Disease category Pathologies
Diabetic retinopathy Diabetic macular oedema, Proliferative diabetic retinopathy, including retinal detachment 
Optic atrophy Ischemic, compressive, toxic, traumatic, autoimmunogenic, excluding optic atrophies secondary to 
glaucoma and uveitic syndromes
Cataract All types of cataract
Retinal vascular disease Central retinal vein occlusion and central retinal artery occlusions not associated with uveitic syndromes
Corneal opacities Corneal degenerations, traumatic, postinfectious, iatrogenic 
Congenital eye anomalies Microphthalmus, albinism, anopthalmus, Peters anomaly, optic disc and chorioretinal coloboma
Myopic degenerations Myopic macular degeneration, retinal detachment
Glaucoma All primary and secondary glaucomas, congenital glaucoma 
Retinal dystrophy Retinitis pigmentosa, Usher syndrome, Stargardt disease, Bietti crystalline dystrophy, choroideraemia
Age-related macular degeneration Senile macular degenerations and all macular scars of unknown etiology
Phthisis bulbi/absent globe Traumatic, postsurgical
Uveitis Behçet syndrome, sarcoidosis
Amblyopia Deprivation amblyopia due to delayed congenital cataract surgery, aphakia
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the 18–50 years age group were similar (P = 0.378), but in 
the 50+ years group, the top 3 pathologies for low vision 
and blindness tended to differ (P = 0.058). 
Discussion
Meta-analysis of population-based studies showed that 
the causes of blindness differ substantially by region 
(5), with the prevalence of cataract being lowest and 
that of macular degeneration being greatest in the high-
est-income regions. Worldwide, more women than men 
were blind or had low vision (5). Turkey can be classified 
among the low- to middle-income countries, but includes 
regions with varying socioeconomic, geographic, and 
ethnic characteristics (6). 
The Turkish Statistical Institute ran a study throughout 
the country based on questionnaire assessments rather 
than clinical examinations in 2002 and found the 
prevalence of visual impairment in Izmir region to be 
0.69% (7). However, this study did not give any information 
about the main pathologies causing visual impairment. 
The current study provides reliable information about 
the causes of low vision and blindness in the adult 
population of Izmir: the major causes of blindness and 
low vision were, in order, retinal dystrophies, congenital 
eye anomalies and myopic degeneration for the 18–50 
years age group. Age-related macular degenerations, 
diabetic retinopathy and corneal opacities were the most 
common causes of visual impairment for the 50+ years 
age group. Cataract and glaucoma were not among the 
3 leading causes of total visual impairment, but cataract 
was the third most common in the low vision category, 
and glaucoma was the third most common in blindness 
category in 50+ years group. Major causes of vision loss 
were unavoidable diseases, and no gender predilection 
was observed. 
Recently, Kivanc et al. reported a similar study 
from Erzurum region in Turkey (8). Although their 
study population was also selected from health council 
medical records, they studied subjects aged 64 years or 
over and used a different disease categorization method, 
which precludes direct comparison with our results. 
However, cataract was the leading cause of low vision, 
and the second most common cause of blindness after 
glaucoma in their group. Besides, women constituted 
the majority (64%) of their blind group. Both cataract, and 
glaucoma are avoidable causes of visual impairment. The 
differences between the 2 regions of Turkey might result 
from the possible differences in access to and use of eye 
care services between the regions. Erzurum is located 
in the eastern part of Turkey, and both geographic and 
socioeconomic characteristics are rather different from 
Izmir.
One of the main findings of our study was that retinal 
dystrophies were the most common reason for low vision 
and blindness in the 18–50-year-old population. Retinal 
dystrophies were not found as a major cause of visual 
impairment in the study from Erzurum because that 
study was not done on an age-matching group (8). Retinal 
dystrophies have also been reported as one of the main 
causes of blindness in Scandinavian (28.6%), German 
(22%), English, (8.2%) and Chinese populations (7.7%) 
(9–12). To provide a better comparison, studies detailing 
Table 2 Distribution according to sex and age of the leading causative pathologies in 347 people with low vision and blindness in 
Izmir, Turkey, 2012–2013
Pathology Age (years) Total
18–50 50+
Females Males Females Males
No. % No. % No. % No. % No. %
Diabetic retinopathy 0 0.0 4 7.7 18 14.4 24 20.0 46 13.3
Optic atrophy 6 12.0 4 7.7 8 6.4 8 6.7 26 7.5
Cataract 0 0.0 0 0.0 17 13.6 12 10.0 29 8.4
Retinal vascular disease 0 0.0 0 0.0 0 0.0 2 1.7 2 0.6
Corneal opacities 3 6.0 4 7.7 17 13.6 17 14.2 41 11.8
Congenital eye anomalies 4 8.0 10 19.2 3 2.4 4 0 3.3 21 6.1
Myopic degenerations 7 14.0 6 11.5 12 9.6 5 4.1 30 8.7
Glaucoma 2 4.0 1 1.9 10 8.0 11 9.2 24 6.9
Retinal dystrophies 20 40.0 18 34.6 12 9.6 9 7.5 59 17.0
Age-related macular degeneration 0 0.0 1 1.9 27 21.6 25 20.8 53 15.3
Phthisis bulbi/absent globe 1 2.0 0 0.0 0 0.0 1 0.8 2 0.6
Uveitis 3 6.0 1 1.9 0 0.0 1 0.8 5 1.4
Amblyopia 4 8.0 3 5.8 1 0.8 1 0.8 9 2.6
Total 50 100.0 52 100.0 125 100.0 120 100.0 347 100.0
P-value 0.378 0.686
< 0.001
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major causes of visual impairment from countries with 
different income levels have been listed on Table 4. Retinal 
dystrophies were usually not reported as a major cause of 
visual loss in middle- to lower-income countries (8,13–16). 
It is possible that a higher proportions of uncorrected 
refractive error and cataract might be masking retinal 
dystrophies in those regions of the world. 
Congenital eye anomalies were the second most 
common (15.9%) pathology causing blindness in the 18–50 
years age group, and predominantly affected males (19.2% 
vs 8%). It is difficult to compare our findings with other 
studies, because either a congenital eye malformations 
were not categorized or they were categorized under 
“others” in many of the studies (9,10,14–16). Finger et al. 
categorized congenital malformations and retinopathy 
of prematurity together in the “others” category (10), 
and this category accounted for blindness in 37.2% of a 
German population (Table 4). Congenital eye anomalies 
were reported as the cause of blindness in 4% of the blind 
registered Australian and 2.1% of the blind registered 
English populations (11,17). Strikingly higher proportions 
of visual impairment associated with congenital eye 
anomalies in our study population might have arisen 
from limited access to eye care services in the past and 
lack of timely treatment in some cases.
We found that myopic degenerations were the second 
most common cause of low vision, (13.8%) and the third 
most common cause of blindness (11.4%) in the 18–50 
years age group; females were more commonly affected. 
Similar proportions for myopic degenerations have been 
reported in Scandinavian (14%), Australian (9.5%), Chinese 
(7.7 %), and German (7.5%) populations (9,10,12,17). For the 
myopia-related low vision category reported proportions 
were: 32.7% for Chinese, 26% for Scandinavian and 12.2% for 
Japanese populations (9,12,18). On the other hand, myopic 
degeneration was not categorized in studies from both 
lower- (India, Pakistan, Iran, Brazil, Oman), and higher-
income (United States of America, England and Wales) 
regions of the world (11,13–16,19,20). Myopic degenerations 
might be categorized under headings like “others”, “other 
retinal diseases”, “maculopathy”, “uncorrected refractive 
errors” and “macular degeneration” in different studies, 
and this might lead to a false impression that they are 
very rare in some populations. Another possibility is 
that higher proportions of cataract might be masking 
posterior segment problems like myopic degenerations.
Age-related macular degeneration is reported as the 
most common cause of low vision and blindness in many 
high-income countries except for Japan (11,17,18,20). It was 
also the leading cause of low vision (24.1%) and blindness 
(18.8%) in both males and females in the 50+ years age 
group in Izmir, but the proportion of the population blind 
because of age-related macular degeneration was not 
particularly high compared with the proportions from 
higher-income countries, where age-related macular 
degeneration was the major cause of blindness in 27–65% 
of the cases (9,10,17,20). On the other hand, age-related 
macular degeneration was not reported among the major 
causes of low vision and blindness, or had a minor role, 
in most of the low- and middle-income countries (12–16). 
Diabetes mellitus is one of the most common chronic 
diseases in nearly all countries, and the prevalence 
is expected to increase as changing lifestyles lead to 
reduced physical activity and increased obesity (21). 
Table 3 Distribution according to age of the leading causative pathologies for low vision and blindness in 347 people in Izmir, 
Turkey, 2012–2013
Pathology Age (years) Total 
18–50 50+
Low vision Blindness Low vision Blindness
No. % No. % No. % No. % No. %
Diabetic retinopathy 3 5.2 1 2.3 25 22.3 17 12.8 46 13.3
Optic atrophy 5 8.6 5 11.4 7 6.3 9 6.8 26 7.5
Cataract 0 0.0 0 0.0 16 14.3 13 9.8 29 8.4
Retinal vascular disease 0 0.0 0 0.0 1 0.9 1 0.8 2 0.6
Corneal opacities 4 6.9 3 6.8 15 13.4 19 14.3 41 11.8
Congenital eye anomalies 7 12.1 7 15.9 3 2.7 4 3.0 21 6.1
Myopic degenerations 8 13.8 5 11.4 7 6.3 10 7.5 30 8.7
Glaucoma 1 1.7 2 4.5 3 2.7 18 13.5 24 6.9
Retinal dystrophy 21 36.2 17 38.6 6 5.4 15 11.3 59 17.0
Age-related macular degeneration 1 1.7 0 0.0 27 24.1 25 18.8 53 15.3
Phthisis bulbi/absent globe 0 0.0 1 2.3 0 0.0 1 0.8 2 0.6
Uveitis 2 3.4 2 4.5 0 0.0 1 0.8 5 1.4
Amblyopia 6 10.3 1 2.3 2 1.8 0 0.0 9 2.6
Total 58 100.0 44 100.0 112 100.0 133 100.0 347 100.0
P-value
0.786 0.063
0.058
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Recent studies have reported that the prevalence of 
diabetes mellitus in Turkey is increasing rapidly: a 90% 
increase from 1999 to 2010 has been reported (22). Diabetic 
retinopathy was the second leading cause of low vision 
and the fourth leading cause of blindness in the 50+ 
years age group in our study, predominantly affecting the 
male population. Blindness due to diabetic retinopathy 
was comparable in German (20%), Scandinavian (14%), 
Hispanic American (14.3%), Black American (7.3%) and 
Chinese (7.7%) populations (9,10,12,20). However, it did not 
seem to be such a major problem in countries like Japan, 
Australia, Islamic Republic of Iran, Pakistan, Poland or 
Brazil although they had comparable prevalence rates of 
diabetes mellitus (13,15–18,21,23). This might be attributed 
to better control of diabetes mellitus, timely treatment 
of diabetic eye complications, or under-representation 
of diabetic retinopathy as a cause of visual impairment 
because of higher prevalence of cataract. Besides, cataract 
itself might be a complication of diabetes mellitus.
Cataract was reported the cause of 33.4% of all 
blindness in 2010, and 18.4% of all low vision worldwide 
(24). It was a major cause of blindness in low-income 
countries like India (62.4%), Pakistan (51.5%) and China 
(38.5%), but in high-income countries it was often reported 
as a major cause of low vision (9,11–14,17). Cataract surgery 
can be readily performed in hospitals in Izmir, and it was 
not a major cause of blindness, however, it was the third 
most common cause of low vision in the 50+ years age 
group (14.3%).
Glaucoma had a unique distribution in visually 
impaired patients. Glaucoma patients usually preserve 
a good level of visual acuity until the end stage of 
the disease. Consistent with this, glaucoma was not 
found to be a common cause of low vision in our study, 
although it was the third most common cause of blinding 
pathology after age-related macular degeneration and 
diabetic retinopathy in the 50+ years age group. A similar 
distribution of glaucoma-related visual impairment was 
observed in Scandinavian, Hispanic American and Black 
American populations (9,20). Glaucoma was the leading 
cause of blindness in Hispanic Americans, with a typical 
distribution of 28.6% in the blind group, and a much 
lower 7.6% in the low vision group (20). It was reported 
as a common cause of blindness in both high- and low-
income countries, e.g. Germany (15%), China (7.7%) and 
Pakistan (7.1%) (10,12,13). Visual impairment, caused by 
glaucoma, can be prevented by early detection and close 
follow-up of the affected individuals. Primary open-angle 
Table 4 Comparison of leading causes of low vision and blindness reported in studies in selected countries 
Region and date No. Age (years) Criteria for LV&B Leading causes of LV&B
Izmir/Turkey 2016 (this study) 44 18–50 WHO (LV&B) Retinal dystrophies, malformations, MRD
133 50+ WHO (LV&B) AMD, DRP, corneal opacities
Erzurum, Turkey 2016 (8) 71 65+ WHO (LV&B) Cataract, glaucoma, AMD
Beijing, China 2006 (12) 62 40+ WHO (LV&B) Cataract, MRD, glaucoma
Iran 2015 (15) 156 All ages WHO (LV&B) Uncorrected refractive error, cataract, AMD
Brazil 2009 (16) 42 All ages WHO (LV&B) Uncorrected refractive error, Cataract, retinal 
diseases
Pakistan 2014 (13) 2 927 30+ WHO (LV&B) Cataract, uncorrected refractive error and 
aphakia
India 2014 (14) 1 609 50+ WHO (LV&B) Uncorrected refractive error, cataract, retinal 
disease
USA (white) 2004 (20) 937 000a 40+ USA (B) AMD, cataract, glaucoma
USA (Hispanic) 2004 (20) 937 000a 40+ USA (B) Glaucoma, AMD, DRP
USA (black) 2004 (20) 937 000a 40+ USA (B) Cataract, glaucoma, DRP
Germany 2015 (10) 949 20–60 WHO (B) Malformations and ROP, retinal dystrophy, 
glaucoma
1 465 61–80 WHO (B) AMD, DRP, malformations and ROP
Copenhagen, Denmark 2004 (9) 209 20–64 USA (LV&B) MRD, other retinal diseases, DRP
320 65–84 USA (LV&B) Cataract, AMD, DRP
Australia 2011 (17) 273 All ages USA (B) AMD, glaucoma, retinal dystrophies
England and Wales 2013 (11) 10 781 All ages WHO (B) AMD, glaucoma, retinal dystrophies
Poland 2015 (23) 20 35+ USA (LV&B) AMD, cataract, glaucoma
Japan 2006(18) 25 40+ USA (LV&B) Cataract, MRD, glaucoma
Oman 2014 (19) 134 All ages WHO (B) Cataract, trachomatous corneal opacities, 
glaucoma
WHO = World Health Organization; LV&B = low vision and blindness; MRD = myopic retinal disease; AMD = age related macular degenerations; DRP = diabetic retinopathy; USA = United 
States of America; ROP = retinopathy of prematurity. 
aEstimated number.
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glaucoma, which is the most common type observed in 
our population, usually does not cause signs or symptoms, 
and is diagnosed during ophthalmologic examination for 
other reasons. Early diagnosis of all cases is only possible 
by regular screening programmes aimed towards age 
groups of the population with a relatively higher risk.
Corneal opacities arising from various causes were 
the third most common cause of visual impairment in 
both men and women aged 50+ years. They were also the 
third most common cause of blindness in the 50+ years 
age group. Corneal opacities were not reported among 
the common causes of low vision and blindness in high-
income countries (9–11), but they were the second most 
common cause of blindness in studies from Pakistan 
(11.8%) and China (15.4%) (12,13). Higher proportions 
of blindness due to corneal opacities were especially 
reported in countries where trachoma was seen 
endemically (19,25). Trachoma was not seen in Turkey. 
Causes of corneal opacities in the study population 
were corneal degeneration, trauma, post infection (non-
trachomatous), iatrogenic and idiopathic. 
A limitation of this study was that it had to rely on 
data collected by the health council, and maintained 
in their archives, with no opportunity to verify the 
diagnosis. However, all reports submitted were based on 
examinations completed by a senior ophthalmologist; 
therefore, the level of accuracy is assumed to be high. 
Conclusions
There was no sex difference in the distribution of the 
pathologies causing low vision and blindness, but there 
were significant differences due to age. Among adults 
aged 18-50 years, especially retinal dystrophies and con-
genital eye anomalies had striking high percentages 
compared to other countries. Identifying the inheritance 
pattern and the causative genetic mutations in the af-
fected patients might facilitate genetic counselling, and 
consequently reduce the disease incidence in the next 
generations (26). 
Age-related macular degenerations, diabetic 
retinopathy and corneal opacities were the predominant 
pathologies causing low vision and blindness in persons 
aged 50+ years. Age-related macular degeneration is not 
preventable; as the life expectancy of the population 
increases, the prevalence of age-related macular 
degeneration is also expected to increase, and health 
service planners should consider the medical and social 
service requirements for this cohort of the population. 
On the other hand, diabetic retinopathy is preventable: 
awareness of glycaemic control is necessary to prevent 
vision-threatening complications of diabetes. 
Corneal opacities have strikingly higher proportions 
among the visually impaired population although it is 
a treatable pathology. In 2013, the Turkish government 
allowed the importation of corneas and the law on organ 
and tissue transplantation was changed in 2014, allowing 
corneas to be taken from dead donors unless they left 
a signed will prohibiting it. Thus, we can expect that 
corneal opacities might not be a major cause of visual 
impairment in the region in the near future, and our 
findings may provide a firm basis for the future planning 
and strengthening of comprehensive eye care services in 
Izmir.
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Causes de la faible vision et de la cécité dans une population adulte turque : étude de 
santé oculaire à Izmir
Résumé
Contexte : En Turquie, les données montrent que les maladies des organes des sens représentaient la deuxième cause 
d’années de vie perdues en raison d’une incapacité en 2015. Cependant, il n’existe de données fiables ni sur les troubles 
de base à l’origine de la déficience visuelle, ni sur la charge de ces troubles dans la population de la région d’Izmir. Izmir 
constitue la troisième ville la plus peuplée de Turquie, avec une population d’environ 4,2 millions d’habitants.
Objectif : La présente étude avait pour objectif de définir les troubles de base à l’origine d’une faible vision et de la cécité 
dans une population adulte d’Izmir, selon les critères de l’Organisation mondiale de la Santé.
Méthodes : Nous avons évalué les rapports ophtalmologiques de 20 790 personnes à Izmir (Turquie). Les causes de la 
faible vision et de la cécité liées à l’âge et au sexe ont été identifiées.
Résultats : Une faible vision et une cécité bilatérales ont été détectées chez 347 personnes, dont 172 hommes et 
175 femmes. Pour les sujets âgés de 18 à 50 ans, les dystrophies rétiniennes (37 %), les anomalies oculaires 
congénitales (14 %) et la dégénérescence myopique (13 %) constituaient les causes les plus courantes. Pour ceux âgés de 
plus de 50 ans, la dégénérescence maculaire (21 %) liée à l’âge était la cause principale. La rétinopathie diabétique (17 %), 
les opacités cornéennes (14 %), la cataracte (12 %) et le glaucome (9 %) étaient aussi des causes importantes. Le sexe ne 
constituait pas un déterminant significatif.
Conclusion : Les causes spécifiques de la déficience visuelle varient grandement en fonction de l’âge ; néanmoins, les 
pathologies rétiniennes non évitables étaient les causes prédominantes à tout âge.
Research article
167
EMHJ – Vol. 24 No. 2 – 2018
 يرمزإ في نويعلا ضارمأ لوح ةسارد :ايكرت في ينغلابلا ناكسلا تاعوممج ىدحإ في ىمعلاو راصبلإا فعض بابسأ
لوكادروي يفص هفيزان ،ندرا هرمأ سييو ،جوك يارف
ةصلالخا
 دجوت لا هنأ ديب .2015 ماع في ةقاعلإا ببسب رمعلا يننس عايض بابسأ مهأ نياث يه ساولحا ضارمأ نأ ايكرت نم ةدمتسلما تانايبلا رهظت :ةيفللخا
 يرمزإ دعتو .يرمزإ ميلقإ في ناكسلا لىع تابارطضلاا هذه ءبع نع وأ راصبلإا فعضل ةببسلما ةيساسلأا تابارطضلاا نع ًءاوس ةقوثوم تانايب
.ةمسن نويلم 4.2 وحن انهاكس دادعت غلبي ثيح ،ايكرت في ناكسلا ثيح نم ندلما بركأ ثلاث
 ىدل ةيلماعلا ةحصلا ةمظنم يرياعم قفو ىمعلاو راصبلإا فعضل ةبِّبسلما ةيساسلأا تابارطضلاا ديدتح في ةساردلا هذه نم ضرغلا لثتم :فدلها
.يرمزإ في ينغلابلا ناكسلا نم ةعوممج
 رمعلا بسح يمعلاو راصبلإا فعض بابسأ ديدتح متو .ايكترب يرمزإ في ًاصخش 20 790 هعوممج الم نويعلا ريراقتل ًماييقت انيرجأ :ثحبلا قرط
.سنلجاو
 في ًاعويش بابسلأا رثكأ تلثتمو .ةأرما 175و ًلاجر 172 مهنم ،ىمعلاو يننيعلا في راصبلإا فعض نم نوناعي اوناك ًاصخش 347 نأ ّينبت :جئاتنلا
 ةيرمعلا ةئفلل ةبسنلابو .)%13( رظنلا َصِق روهدتو )%14( ةيقللخا ينعلا تافارحنا و )%37( يكبشلا رومضلا في ًاماع 50-18 ةيرمعلا ةلحرلما
 )%17( يركسلا ةيكبشلا للاتعا ًاضيأ ةمهلما بابسلأا ينب نم ءاجو .)%21( يعَقُبلا روهدتلا في ةباصلإا في سييئرلا ببسلا لثتم ،لىعأ مايف 50
.ًماهم ًاددمح ضيرلما سنج لثمي لمو .)%9( )قَرَزلا( ينعلا طغض عافتراو )%12( ينعلا ةسدع ماتعإو )%14( ةينرقلا ةماتعو
 ًاراشتنا بابسلأا رثكأ ثودلحا ةيمتلحا ةيكبشلا ضارمأ تلكش نئلو ،نسلا عم ًايربك ًاتوافت راصبلإا فعضل ةددحلما بابسلأا توافتت :جاتنتسلاا
.ةيرمعلا تائفلا عيجم في راصبلإا فعضل
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